GRM5 (P41594) variants and mutations
GRM5 (also known as P41594) is a human protein-coding gene encoding a metabotropic glutamate receptor 5 protein. Its activation by glutamate engages Gq-dependent intracellular signaling and modulates synaptic plasticity, excitability, and learning-related circuits. Abnormal signaling has been implicated in several neuropsychiatric and neurodevelopmental disorders and remains a target of experimental therapeutics. This analysis covers 1,860 GRM5 variants and mutations. Of these, 73% have computational variant effect predictions. Disease context includes major depressive disorder, skin neoplasm, and retinal detachment. Example GRM5 variants include M1?, V2A, and V2F.
Variant analysis overview
- Gene: GRM5
- Protein: P41594
- UniProt accession: P41594
- Organism: Homo sapiens
- Variants analyzed: 1860
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 1,329 unspecified-consequence records; 1 stop lost; 168 synonymous variants; 319 missense variants; 6 in-frame deletions; 19 stop-gained variants; 4 in-frame insertions; 15 frameshift variants
- Prediction scores: 1,366 variants have prediction scores (73% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: major depressive disorder, skin neoplasm, retinal detachment, skin cancer, cutaneous melanoma, benign neoplasm of eye, actinic keratosis, autism spectrum disorder, alcohol drinking, neurotic disorder, smoking initiation, skin disorder.
Protein structure and variant hotspots
- Protein features: 7 transmembrane segments; 6 binding sites; 11 post-translational modification sites.
- Structural context: 121 variants have structural context.
- PTM context: 18 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable GRM5 variants
Examples include M1?, V2A, V2F, L4M, S8*, S8P, V9A, V9I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV5958, cosmic curated COSV59587, Variant assessed as somatic; high impact.
- V2A (p.Val2Ala), ExAC rs78375107, TOPMed rs78375107, gnomAD rs78375107, REVEL 0.34, MetaLR 0.69
- V2F (p.Val2Phe), gnomAD rs1366355209, REVEL 0.58, MetaLR 0.70
- L4M (p.Leu4Met), cosmic curated COSV59595, gnomAD rs1447134591, REVEL 0.40, MetaLR 0.80
- S8* (p.Ser8Ter), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59605, Variant assessed as somatic; high impact.
- S8P (p.Ser8Pro), NCI-TCGA Cosmic COSV5963, cosmic curated COSV59630, Variant assessed as somatic; moderate impact.
- V9A (p.Val9Ala), TOPMed rs1472903623
- V9I (p.Val9Ile), rs778784135, ExAC rs778784135, REVEL 0.21, MetaLR 0.53, Variant assessed as somatic; moderate impact.
- L10F (p.Leu10Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L11R (p.Leu11Arg), NCI-TCGA Cosmic COSV5962, Variant assessed as somatic; moderate impact.
- K13N (p.Lys13Asn), gnomAD rs1206789605
- E14G (p.Glu14Gly), ExAC rs754913759, gnomAD rs754913759, REVEL 0.44, MetaLR 0.69
- E14K (p.Glu14Lys), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59605, NCI-TCGA Cosmic COSV5961, REVEL 0.44, MetaLR 0.72, Variant assessed as somatic; moderate impact.
- V16A (p.Val16Ala), NCI-TCGA Cosmic COSV5959, cosmic curated COSV59597, NCI-TCGA Cosmic COSV5960, Variant assessed as somatic; moderate impact.
- V16D (p.Val16Asp), cosmic curated COSV59606, gnomAD rs1358659195, REVEL 0.53, MetaLR 0.57
- V16I (p.Val16Ile), gnomAD rs1229855231, REVEL 0.32, MetaLR 0.65
- R17C (p.Arg17Cys), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59607, REVEL 0.25, MetaLR 0.54, Variant assessed as somatic; moderate impact.
- R17H (p.Arg17His), 1000Genomes rs200406314, ExAC rs200406314, TOPMed rs200406314, gnomAD rs200406314, REVEL 0.24, MetaLR 0.63
- G18E (p.Gly18Glu), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- S19G (p.Ser19Gly), cosmic curated COSV10518, ExAC rs780067745, gnomAD rs780067745, REVEL 0.30, MetaLR 0.75
- S19R (p.Ser19Arg), gnomAD rs1323109091, REVEL 0.48, MetaLR 0.60
- Q21* (p.Gln21Ter), gnomAD rs1433464941
- Q21H (p.Gln21His), gnomAD rs1388587276, REVEL 0.43, MetaLR 0.87
- Q21K (p.Gln21Lys), gnomAD rs1433464941
- S23N (p.Ser23Asn), ExAC rs750584568, TOPMed rs750584568, gnomAD rs750584568, REVEL 0.18, MetaLR 0.52
- S23T (p.Ser23Thr), ExAC rs750584568, TOPMed rs750584568, gnomAD rs750584568, REVEL 0.19, MetaLR 0.57
- R25K (p.Arg25Lys), Ensembl rs867324465
- R25W (p.Arg25Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V27M (p.Val27Met), rs751918108, ClinGen CA6220984, ClinVar RCV004170848, ExAC rs751918108, REVEL 0.52, MetaLR 0.87, Uncertain significance, not specified
- V28M (p.Val28Met), ExAC rs764553864, gnomAD rs764553864, REVEL 0.40, MetaLR 0.74
- H30Y (p.His30Tyr), 1000Genomes rs544404398, REVEL 0.31, MetaLR 0.42
- M31I (p.Met31Ile), ExAC rs773060067, TOPMed rs773060067, gnomAD rs773060067, REVEL 0.32, MetaLR 0.32
- M31V (p.Met31Val), ExAC rs760419806, TOPMed rs760419806, gnomAD rs760419806, REVEL 0.24, MetaLR 0.38
- P32L (p.Pro32Leu), rs1287949065, cosmic curated COSV59588, gnomAD rs1287949065, REVEL 0.45, MetaLR 0.62, Variant assessed as somatic; moderate impact.
- P32Q (p.Pro32Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P32S (p.Pro32Ser), gnomAD rs200353980, REVEL 0.36, MetaLR 0.52
- P32T (p.Pro32Thr), NCI-TCGA TCGA novel, REVEL 0.44, MetaLR 0.57, Variant assessed as somatic; moderate impact.
- G33V (p.Gly33Val), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, NCI-TCGA Cosmic COSV5960, Variant assessed as somatic; moderate impact.
- I35M (p.Ile35Met), ESP rs138497785, ExAC rs138497785, TOPMed rs138497785, gnomAD rs138497785, REVEL 0.70, MetaLR 0.77, Uncertain significance, not specified
- I36V (p.Ile36Val), gnomAD rs1299864472, REVEL 0.43, MetaLR 0.67
- G38E (p.Gly38Glu), Ensembl rs200879242
- A39P (p.Ala39Pro), Ensembl rs1565351102, REVEL 0.91, MetaLR 0.80
- A39S (p.Ala39Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- L40V (p.Leu40Val), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- S42P (p.Ser42Pro), cosmic curated COSV10055, gnomAD rs1941673321, REVEL 0.66, MetaLR 0.53
- S42Y (p.Ser42Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V43A (p.Val43Ala), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59604, Variant assessed as somatic; moderate impact.
- V43G (p.Val43Gly), Ensembl rs1591076554
- H44N (p.His44Asn), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- H45Q (p.His45Gln), cosmic curated COSV59614, ExAC rs768500067, gnomAD rs768500067, REVEL 0.68, MetaLR 0.62
- D50E (p.Asp50Glu), cosmic curated COSV59595, ExAC rs749182245, TOPMed rs749182245, gnomAD rs749182245, REVEL 0.47, MetaLR 0.63
- K51E (p.Lys51Glu), ExAC rs199965117, gnomAD rs199965117, REVEL 0.60, MetaLR 0.63
- K51N (p.Lys51Asn), TOPMed rs1252891643, gnomAD rs1252891643, REVEL 0.54, MetaLR 0.66
- V52I (p.Val52Ile), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59607, REVEL 0.38, MetaLR 0.71, Variant assessed as somatic; moderate impact.
- E54D (p.Glu54Asp), rs1439046675, NCI-TCGA Cosmic COSV5963, cosmic curated COSV59637, gnomAD rs1439046675, REVEL 0.61, MetaLR 0.64, Variant assessed as somatic; moderate impact.
- K56T (p.Lys56Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G58R (p.Gly58Arg), rs973046080, NCI-TCGA Cosmic COSV5960, cosmic curated COSV59602, TOPMed rs973046080, AlphaMissense 1.00, MetaLR 0.82, Variant assessed as somatic; moderate impact.
- G58V (p.Gly58Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A59T (p.Ala59Thr), TOPMed rs1941671193, REVEL 0.12, MetaLR 0.22
- A59V (p.Ala59Val), rs756243558, ExAC rs756243558, TOPMed rs756243558, gnomAD rs756243558, REVEL 0.19, MetaLR 0.15, Variant assessed as somatic; moderate impact.
- R61C (p.Arg61Cys), cosmic curated COSV59634, gnomAD rs1429940712, REVEL 0.51, MetaLR 0.46
- R61H (p.Arg61His), rs781430828, NCI-TCGA Cosmic COSV5963, cosmic curated COSV59630, ExAC rs781430828, REVEL 0.45, MetaLR 0.48, Variant assessed as somatic; moderate impact.
- R61S (p.Arg61Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, NCI-TCGA Cosmic COSV5963, Variant assessed as somatic; moderate impact.
- E62* (p.Glu62Ter), gnomAD rs1166105452, CADD 36.00
- Q63H (p.Gln63His), 1000Genomes rs79165784, ESP rs79165784, ExAC rs79165784, TOPMed rs79165784, REVEL 0.52, MetaLR 0.49, Benign
- G65C (p.Gly65Cys), Ensembl rs2135151502
- G65D (p.Gly65Asp), rs751888494, ExAC rs751888494, AlphaMissense 1.00, MetaLR 0.58, Variant assessed as somatic; moderate impact.
- I66F (p.Ile66Phe), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- I66T (p.Ile66Thr), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- R68I (p.Arg68Ile), NCI-TCGA Cosmic COSV5961, cosmic curated COSV59610, Variant assessed as somatic; moderate impact.
- E70* (p.Glu70Ter), NCI-TCGA Cosmic COSV5960, Variant assessed as somatic; high impact.
- L73M (p.Leu73Met), cosmic curated COSV59619, ExAC rs200015333, TOPMed rs200015333, gnomAD rs200015333, REVEL 0.28, MetaLR 0.32, Uncertain significance, not specified
- T75N (p.Thr75Asn), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- L76Q (p.Leu76Gln), TOPMed rs1941670107
- L76V (p.Leu76Val), ExAC rs201710799, TOPMed rs201710799, gnomAD rs201710799, REVEL 0.58, MetaLR 0.44
- E77K (p.Glu77Lys), NCI-TCGA Cosmic COSV5959, cosmic curated COSV59599, Variant assessed as somatic; moderate impact.
- R78K (p.Arg78Lys), cosmic curated COSV59592, ExAC rs772818735, TOPMed rs772818735, gnomAD rs772818735, REVEL 0.61, MetaLR 0.59
- R78M (p.Arg78Met), ExAC rs772818735, TOPMed rs772818735, gnomAD rs772818735
- N80D (p.Asn80Asp), gnomAD rs1277050421, REVEL 0.92, MetaLR 0.92
- N80S (p.Asn80Ser), ExAC rs761478505, gnomAD rs761478505, REVEL 0.93, MetaLR 0.92
- D82G (p.Asp82Gly), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59604, Variant assessed as somatic; moderate impact.
- P83H (p.Pro83His), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- P83S (p.Pro83Ser), Ensembl rs1941669719
- T84I (p.Thr84Ile), TOPMed rs1941669667
- L85F (p.Leu85Phe), TOPMed rs199767728
- L85P (p.Leu85Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L85V (p.Leu85Val), TOPMed rs199767728, REVEL 0.28, MetaLR 0.44
- P87L (p.Pro87Leu), ExAC rs769685723, gnomAD rs769685723, REVEL 0.87, MetaLR 0.73
- P87S (p.Pro87Ser), ExAC rs775471544, TOPMed rs775471544, gnomAD rs775471544, REVEL 0.83, MetaLR 0.66
- N88S (p.Asn88Ser), NCI-TCGA Cosmic COSV5959, cosmic curated COSV59590, REVEL 0.63, MetaLR 0.78, Variant assessed as somatic; moderate impact.
- I89V (p.Ile89Val), ESP rs138949490, gnomAD rs138949490, REVEL 0.16, MetaLR 0.21
- T90I (p.Thr90Ile), TOPMed rs1003036477, gnomAD rs1003036477, REVEL 0.46, MetaLR 0.57
- G92C (p.Gly92Cys), NCI-TCGA Cosmic COSV5959, NCI-TCGA Cosmic COSV5961, cosmic curated COSV59614, Variant assessed as somatic; moderate impact.
- G92D (p.Gly92Asp), NCI-TCGA Cosmic COSV5959, cosmic curated COSV59595, NCI-TCGA Cosmic COSV5960, Variant assessed as somatic; moderate impact.
- G92R (p.Gly92Arg), NCI-TCGA Cosmic COSV5959, cosmic curated COSV59596, NCI-TCGA Cosmic COSV5961, Variant assessed as somatic; moderate impact.
- E94* (p.Glu94Ter), Ensembl rs2135151358
- E94G (p.Glu94Gly), cosmic curated COSV10643, Ensembl rs2135151354
- D97N (p.Asp97Asn), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- S98Y (p.Ser98Tyr), rs781196829, NCI-TCGA Cosmic COSV5959, cosmic curated COSV59595, 1000Genomes rs781196829, REVEL 0.75, MetaLR 0.50, Variant assessed as somatic; moderate impact.
- C99F (p.Cys99Phe), Ensembl rs200671039
- C99S (p.Cys99Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- W100C (p.Trp100Cys), NCI-TCGA TCGA novel, REVEL 0.60, MetaLR 0.44, Variant assessed as somatic; moderate impact.
- W100L (p.Trp100Leu), NCI-TCGA Cosmic COSV5963, cosmic curated COSV59634, Variant assessed as somatic; moderate impact.
- H101N (p.His101Asn), TOPMed rs1227404382
- H101R (p.His101Arg), TOPMed rs1272209457, REVEL 0.50, MetaLR 0.20
- S102L (p.Ser102Leu), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59609, NCI-TCGA Cosmic COSV5963, REVEL 0.51, MetaLR 0.46, Variant assessed as somatic; moderate impact.
- V104M (p.Val104Met), gnomAD rs1177628572, REVEL 0.36, MetaLR 0.39
- Q108* (p.Gln108Ter), NCI-TCGA Cosmic COSV5960, Variant assessed as somatic; high impact.
- Q108E (p.Gln108Glu), gnomAD rs1254238852, REVEL 0.58, MetaLR 0.53
- S109I (p.Ser109Ile), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, NCI-TCGA Cosmic COSV5959, Variant assessed as somatic; moderate impact.
- S109N (p.Ser109Asn), NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV5959, cosmic curated COSV59599, REVEL 0.37, MetaLR 0.54, Variant assessed as somatic; moderate impact.
- S109R (p.Ser109Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I110F (p.Ile110Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E111A (p.Glu111Ala), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59603, NCI-TCGA Cosmic COSV5962, Variant assessed as somatic; moderate impact.
- E111V (p.Glu111Val), NCI-TCGA Cosmic COSV5960, NCI-TCGA Cosmic COSV5962, cosmic curated COSV59625, Variant assessed as somatic; moderate impact.
- F112L (p.Phe112Leu), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, NCI-TCGA Cosmic COSV5958, cosmic curated COSV59587, Variant assessed as somatic; moderate impact.
- I113L (p.Ile113Leu), gnomAD rs1238077235, REVEL 0.59, MetaLR 0.60
- R114I (p.Arg114Ile), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- R114K (p.Arg114Lys), Ensembl rs867401790
- D115E (p.Asp115Glu), 1000Genomes rs140113398, ESP rs140113398, ExAC rs140113398, TOPMed rs140113398, REVEL 0.61, MetaLR 0.61
- D115V (p.Asp115Val), Ensembl rs1591076262
- S116F (p.Ser116Phe), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; moderate impact.
- L117I (p.Leu117Ile), TOPMed rs1278561727, gnomAD rs1278561727
- L117V (p.Leu117Val), TOPMed rs1278561727, gnomAD rs1278561727, REVEL 0.63, MetaLR 0.68
- I118L (p.Ile118Leu), TOPMed rs1941667538
- S119F (p.Ser119Phe), rs774109600, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, ExAC rs774109600, REVEL 0.81, MetaLR 0.78, Variant assessed as somatic; moderate impact.
- S119P (p.Ser119Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S119Y (p.Ser119Tyr), ExAC rs774109600, TOPMed rs774109600, gnomAD rs774109600, REVEL 0.80, MetaLR 0.78
- S120L (p.Ser120Leu), cosmic curated COSV10964, gnomAD rs1286061108, REVEL 0.23, MetaLR 0.40
- E121D (p.Glu121Asp), ExAC rs775240392, gnomAD rs775240392, REVEL 0.57, MetaLR 0.59
- E121K (p.Glu121Lys), ESP rs151133635, ExAC rs151133635, gnomAD rs151133635
- E121Q (p.Glu121Gln), ESP rs151133635, ExAC rs151133635, gnomAD rs151133635, REVEL 0.52, MetaLR 0.79
- E122G (p.Glu122Gly), 1000Genomes rs200319380, ExAC rs200319380, TOPMed rs200319380, gnomAD rs200319380, REVEL 0.49, MetaLR 0.66
- E123* (p.Glu123Ter), Ensembl rs1941667033
- E124G (p.Glu124Gly), gnomAD rs1941666886, REVEL 0.51, MetaLR 0.67
- E124K (p.Glu124Lys), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59603, REVEL 0.58, MetaLR 0.75, Variant assessed as somatic; moderate impact.
- E124Q (p.Glu124Gln), Ensembl rs1941666984, REVEL 0.37, MetaLR 0.73
- G125D (p.Gly125Asp), ExAC rs776573553, TOPMed rs776573553, gnomAD rs776573553, REVEL 0.58, MetaLR 0.84
- G125S (p.Gly125Ser), cosmic curated COSV10518, NCI-TCGA TCGA novel, REVEL 0.37, MetaLR 0.68, Variant assessed as somatic; moderate impact.
- G125V (p.Gly125Val), ExAC rs776573553, TOPMed rs776573553, gnomAD rs776573553, REVEL 0.60, MetaLR 0.85
- L126F (p.Leu126Phe), Ensembl rs1941666484, REVEL 0.28, MetaLR 0.29
- R128C (p.Arg128Cys), rs1409555487, NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV5960, cosmic curated COSV59605, REVEL 0.71, MetaLR 0.63, Variant assessed as somatic; moderate impact.
- R128H (p.Arg128His), rs557855706, NCI-TCGA Cosmic COSV5962, cosmic curated COSV59627, 1000Genomes rs557855706, REVEL 0.58, MetaLR 0.56, Variant assessed as somatic; moderate impact.
- R128S (p.Arg128Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, NCI-TCGA Cosmic COSV5960, Variant assessed as somatic; moderate impact.
- C129S (p.Cys129Ser), Ensembl rs201923611, REVEL 0.52, MetaLR 0.78
- V130M (p.Val130Met), ESP rs144706715, ExAC rs144706715, TOPMed rs144706715, gnomAD rs144706715, REVEL 0.26, MetaLR 0.42
- D131G (p.Asp131Gly), gnomAD rs1482344412, REVEL 0.52, MetaLR 0.50
- D131N (p.Asp131Asn), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59603, Variant assessed as somatic; moderate impact.
- S134F (p.Ser134Phe), cosmic curated COSV59602, TOPMed rs1321899599, gnomAD rs1321899599, REVEL 0.50, MetaLR 0.72
- S136F (p.Ser136Phe), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59601, Variant assessed as somatic; moderate impact.
- S136P (p.Ser136Pro), ExAC rs754338771, gnomAD rs754338771, REVEL 0.12, MetaLR 0.17
- S136Y (p.Ser136Tyr), NCI-TCGA Cosmic COSV5960, cosmic curated COSV59603, Variant assessed as somatic; moderate impact.
- F137L (p.Phe137Leu), cosmic curated COSV10736, ExAC rs267603230, gnomAD rs267603230, REVEL 0.21, MetaLR 0.31
- F137S (p.Phe137Ser), cosmic curated COSV59617, 1000Genomes rs72954992, ExAC rs72954992, gnomAD rs72954992
- F137Y (p.Phe137Tyr), 1000Genomes rs72954992, ExAC rs72954992, gnomAD rs72954992, REVEL 0.31, MetaLR 0.34
- R138C (p.Arg138Cys), cosmic curated COSV59593, 1000Genomes rs538043568, ExAC rs538043568, gnomAD rs538043568, REVEL 0.58, MetaLR 0.69
- R138H (p.Arg138His), cosmic curated COSV59609, 1000Genomes rs569390300, ExAC rs569390300, TOPMed rs569390300, REVEL 0.22, MetaLR 0.38
- R138L (p.Arg138Leu), 1000Genomes rs569390300, ExAC rs569390300, TOPMed rs569390300, gnomAD rs569390300
- K140* (p.Lys140Ter), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, Variant assessed as somatic; high impact.
- K140E (p.Lys140Glu), Ensembl rs1941665405
- K140N (p.Lys140Asn), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, NCI-TCGA Cosmic COSV5962, Variant assessed as somatic; moderate impact.
- K140R (p.Lys140Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K141N (p.Lys141Asn), TOPMed rs1298226315, gnomAD rs1298226315, REVEL 0.66, MetaLR 0.74
- K141R (p.Lys141Arg), Ensembl rs1295196167, REVEL 0.47, MetaLR 0.72
- I143V (p.Ile143Val), gnomAD rs77734657, REVEL 0.39, MetaLR 0.44
- V144A (p.Val144Ala), rs200953711, ClinGen CA6220921, ClinVar RCV004180842, ExAC rs200953711, REVEL 0.64, MetaLR 0.55, Uncertain significance, not specified
- V144I (p.Val144Ile), Ensembl rs1591076080
- G145V (p.Gly145Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V146I (p.Val146Ile), ExAC rs759486728, gnomAD rs759486728
- I147T (p.Ile147Thr), rs1941664701, ClinGen CA382075790, ClinVar RCV004006212, Ensembl rs1941664701, REVEL 0.90, MetaLR 0.83, Uncertain significance, See cases
- I147V (p.Ile147Val), ExAC rs776692816, TOPMed rs776692816, gnomAD rs776692816, REVEL 0.54, MetaLR 0.62, Uncertain significance, not specified
- G148W (p.Gly148Trp), cosmic curated COSV59606, Ensembl rs2135150965, REVEL 0.98, MetaLR 0.97
- S151F (p.Ser151Phe), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10055, NCI-TCGA Cosmic COSV5960, Variant assessed as somatic; moderate impact.
- S151P (p.Ser151Pro), NCI-TCGA Cosmic COSV5961, cosmic curated COSV59613, Variant assessed as somatic; moderate impact.
- S151Y (p.Ser151Tyr), NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV5960, cosmic curated COSV59603, Variant assessed as somatic; moderate impact.
- S153Y (p.Ser153Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A155S (p.Ala155Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A155V (p.Ala155Val), NCI-TCGA Cosmic COSV5959, cosmic curated COSV59597, Variant assessed as somatic; moderate impact.
- Q157* (p.Gln157Ter), NCI-TCGA Cosmic COSV5963, cosmic curated COSV59632, Variant assessed as somatic; high impact.
- Q157H (p.Gln157His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
Public GRM5 analysis runs
- GRM5 analysis run — GRM5 (1,860 variants) — completed 2026-08-21